Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer Moonshot^SM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.

Notice of Funding Opportunities

Title	Announcement Number	Activity Code	Clinical Trials Status Sort descending	Expiration Date	Program Official
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)	NOT-NS-20-107		Clinical Trial Not Allowed	05/16/2024	Brennan Streck, Ph.D., R.N., M.P.H.
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research	RFA-CA-24-009 (R33 Clinical Trial Not Allowed)	R33	Clinical Trial Not Allowed	10/02/2024	Guillermo Marquez, Ph.D.
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research	RFA-CA-24-008 (R61 Clinical Trial Not Allowed)	R61	Clinical Trial Not Allowed	10/02/2024	Guillermo Marquez, Ph.D.
Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)	NOT-OD-22-202		Clinical Trial Not Allowed	04/16/2025	Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Mechanisms that Impact Cancer Risk after Bariatric Surgery	PAR-21-332 (R21 Clinical Trial Not Allowed)	R21	Clinical Trial Not Allowed	09/08/2024	Edward Sauter, M.D., Ph.D.
HEAL Initiative: Studies to Enable Analgesic Discovery	RFA-NS-25-012 (R61/R33 - Clinical Trial Not Allowed)	R61, R33	Clinical Trial Not Allowed	01/16/2027	Rachel Altshuler, Ph.D.
NCI Clinical and Translational Exploratory/Developmental Studies	PAR-22-216 (R21 Clinical Trial Optional)	R21	Clinical Trial Optional	07/02/2025	Marjorie Perloff, M.D.
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes	PAR-22-131 (R01 Clinical Trial Optional)	R01	Clinical Trial Optional	09/08/2025	Richard Mazurchuk, Ph.D.
Understanding Chronic Conditions Understudied Among Women	RFA-OD-23-013 (R21 Clinical Trial Optional)	R21	Clinical Trial Optional	06/21/2024	Goli Samimi, Ph.D., M.P.H.
Understanding Chronic Conditions Understudied Among Women	RFA-OD-23-014 (R01 Clinical Trial Optional)	R01	Clinical Trial Optional	06/21/2024	Goli Samimi, Ph.D., M.P.H.